Meta‐analysis of survival based on resection margin status following surgery for recurrent rectal cancer
- 22 February 2012
- journal article
- review article
- Published by Wiley in Colorectal Disease
- Vol. 14 (12), 1457-1466
- https://doi.org/10.1111/j.1463-1318.2012.03005.x
Abstract
Aim To determine the presence and duration of survival advantages was investigated for resection margin status (R0, R1 or R2) following surgery for locally recurrent rectal cancer (LRRC). Method A systematic review of the literature was performed for studies comparing resection margin status for LRRC. Weighted mean differences and meta‐analysis of hazard ratios were used as a measure of median and overall cumulative survival. Results Twenty‐two studies were included, providing outcome for 1460 patients undergoing surgery for LRRC. 57% underwent an R0 resection, 25% an R1 resection and 11% an R2 resection. The most commonly performed operations were abdominoperineal excision (35%), exenteration (23%) and anterior resection (21%). The range of median survival per resection margin was R0 28–92 months, R1 12–50 months, R2 6–17 months. Patients undergoing an R0 resection survived on average for 37.6 (95% confidence interval: 23.5–51.7) months longer than those undergoing R1 resection and 53.0 (31.2–74.8) months longer than those undergoing R2 resection. This correlated to a hazard ratio of 2.03 (1.73–2.38) for R0 vs R1 and 3.41 (2.21–5.25) for R0 vs R2. Patients undergoing R1 resection survived on average 13.3 (7.23–19.4) months longer than those undergoing R2 resection [hazard ratio of 1.68 (1.33–2.12)]. Conclusion Patients undergoing R0 resection have the greatest survival advantage following surgery for recurrent rectal cancer. There is a survival advantage for R1 over R2 resection, but there may be no benefit of R2 resection over palliative treatment.Keywords
This publication has 40 references indexed in Scilit:
- Prognostic Value of Quality of Life and Pain in Patients with Locally Recurrent Rectal CancerAnnals of Surgical Oncology, 2010
- International Preoperative Rectal Cancer Management: Staging, Neoadjuvant Treatment, and Impact of Multidisciplinary TeamsWorld Journal of Surgery, 2010
- Radical Resection After IORT-Containing Multimodality Treatment is the Most Important Determinant for Outcome in Patients Treated for Locally Recurrent Rectal CancerAnnals of Surgical Oncology, 2008
- Extended Radical Resection: The Choice for Locally Recurrent Rectal CancerDiseases of the Colon & Rectum, 2008
- Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: A single institute experienceEuropean Journal of Surgical Oncology, 2007
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- Surgical treatment of locally recurrent rectal cancerEuropean Journal of Surgical Oncology, 2004
- Mesorectal excision for rectal cancerThe Lancet, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986